American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults with Dyslipidemia - 2025 Update.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Endocrine Practice

• Publication date

  2025-09-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.eprac.2025.07.014PMID 40938233
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ezetimibe plus statin combination versus double-dose statin in patients with dyslipidemia and atherosclerotic cardiovascular disease risk: a comprehensive systematic review and meta-analysis of 47 randomized controlled trials

  2025cited by this paper
• The ACS EuroPath survey series: Time trends in lipid management after an acute coronary syndrome.

  2025cited by this paper
• American Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia.

  2025cited by this paper
• Accelerated Aging in Survivors of Childhood Cancer-Early Onset and Excess Risk of Chronic Conditions.

  2025cited by this paper
• Discrepancy in Metabolic Dysfunction–Associated Steatotic Liver Disease Prevalence in a Large Northern California Cohort

  2025cited by this paper
• Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry.

  2025cited by this paper
• Dyslipidemia management in women of reproductive potential: An expert clinical consensus from the national lipid association.

  2024cited by this paper
• Clinical Outcomes After Acute Coronary Syndromes or Revascularization Among People Living With HIV

  2024cited by this paper
• Changes in Blood Lipids Following Initiation of Gender Affirming Hormone Therapy: A Systematic Review and Meta-Analysis

  2024cited by this paper
• Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome.

  2024cited by this paper
• Fibrates and risk of congenital malformations: a nationwide cohort study in South Korea

  2024cited by this paper
• Prognostic impact of carotid plaque imaging using total plaque area added to SCORE2 in middle-aged subjects: the ARteris Cardiovascular Outcome (ARCO) cohort study.

  2024cited by this paper
• The Heart of the World

  2024cited by this paper
• Genetically proxied low-density lipoprotein cholesterol lowering via PCSK9-inhibitor drug targets and risk of congenital malformations

  2024cited by this paper
• Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America.

  2024cited by this paper
• Efficacy and safety of statin therapy in kidney transplant recipients: a systematic review and meta-analysis

  2024cited by this paper
• Characteristics, Physiopathology and Management of Dyslipidemias in Pregnancy: A Narrative Review

  2024cited by this paper
• Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.

  2024cited by this paper
• 2024 KSoLA consensus on secondary dyslipidemia

  2024cited by this paper
• Dyslipidemia in Human Immunodeficiency Virus Disease: JACC Review Topic of the Week.

  2023cited by this paper
• Dyslipidemia and Cardiovascular Disease Among Childhood Cancer Survivors: A St. Jude Lifetime Cohort Report.

  2023cited by this paper
• Effect of a 1-year physical activity intervention on cardiovascular health in long-term childhood cancer survivors—a randomised controlled trial (SURfit)

  2023cited by this paper
• Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.

  2023cited by this paper
• Medical management of hypertriglyceridemia in pancreatitis

  2023cited by this paper
• Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients.

  2023cited by this paper
• International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia

  2023cited by this paper
• Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association.

  2023cited by this paper
• Carotid ultrasound and Systematic Coronary Risk Assessment 2 (SCORE2) in the prediction of cardiovascular events.

  2023cited by this paper
• Frailty and sarcopenia within the earliest national Dutch childhood cancer survivor cohort (DCCSS-LATER): a cross-sectional study.

  2023cited by this paper
• Lipid profile and risk of cardiovascular disease in adult transgender men receiving cross-sex hormone therapy: a systematic review.

  2023cited by this paper
• The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

  2023cited by this paper
• The effect of statins exposure during pregnancy on congenital anomalies and spontaneous abortions: A systematic review and meta-analysis

  2022cited by this paper
• Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.

  2022cited by this paper
• Evaluation of cardiovascular diseases risk calculators for CVDs prevention and management: scoping review

  2022cited by this paper
• Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association.

  2022cited by this paper
• Gender-affirming estrogen therapy route of administration and cardiovascular risk: a systematic review and narrative synthesis.

  2022cited by this paper
• American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.

  2022cited by this paper
• The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.

  2022cited by this paper
• American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD).

  2022cited by this paper
• Atherosclerotic Disease Risk Stratification Using Ultrasonographic Measurements of Plaque.

  2022cited by this paper
• Approach to patients with hypertriglyceridemia.

  2022cited by this paper
• Statin-Associated Myalgias and Muscle Injury-Recognizing and Managing Both While Still Lowering the Low-Density Lipoprotein.

  2022cited by this paper
• PCSK9 inhibitors safely and effectively lower LDL after heart transplantation: a systematic review and meta-analysis

  2022cited by this paper
• The Effect of Dietary Interventions on Hypertriglyceridemia: From Public Health to Molecular Nutrition Evidence

  2022cited by this paper
• Prevention and Management of Hypertriglyceridemia-Induced Acute Pancreatitis during Pregnancy: A Systematic Review.

  2022cited by this paper
• A Modern Approach to Dyslipidemia

  2021cited by this paper
• Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis

  2021cited by this paper
• A systematic review and meta-analysis on the effects of statins on pregnancy outcomes.

  2021cited by this paper
• Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia

  2021cited by this paper
• Fetal toxicity associated with statins: A systematic review and meta-analysis.

  2021cited by this paper
• A Randomized Pilot Clinical Trial of Pravastatin Versus Placebo in Pregnant Patients at High-Risk of Preeclampsia.

  2021cited by this paper
• 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult.

  2021cited by this paper
• Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.

  2021cited by this paper
• Medical management of metabolic and cardiovascular complications after liver transplantation

  2020cited by this paper
• Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary.

  2020cited by this paper
• Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease

  2020cited by this paper
• Combined resistance and aerobic exercise intervention improves fitness, insulin resistance and quality of life in survivors of childhood haemopoietic stem cell transplantation with total body irradiation

  2020cited by this paper
• Effect of Statin Use on Cardiovascular Events and All-Cause Mortality and in Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis involving 148,722 Participants.

  2020cited by this paper
• Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.

  2020cited by this paper
• Use of PCSK9 Inhibitors in Solid Organ Transplantation Recipients

  2020cited by this paper
• Statin use in patients with non‐HMGCR idiopathic inflammatory myopathies: A retrospective study

  2020cited by this paper
• Efficacy and safety for the achievement of guideline-recommended lower low-density lipoprotein cholesterol levels: a systematic review and meta-analysis.

  2020cited by this paper
• Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.

  2019cited by this paper
• 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2019cited by this paper
• The Chylomicronemia Syndrome Is Most Often Multifactorial

  2019cited by this paper
• Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

  2019cited by this paper
• Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials.

  2019cited by this paper
• Can alternate-day Statin regimen minimize its adverse effects on muscle and tendon? A systematic review.

  2019cited by this paper
• Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis

  2019cited by this paper
• 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.

  2019cited by this paper
• Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyl

  2019cited by this paper
• Effects of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Inclisiran: An Analysis of the ORION-7 and ORION-1 Studies.

  2019cited by this paper
• Clinical review on triglycerides

  2019cited by this paper
• Determinants of Maternal Insulin Resistance during Pregnancy: An Updated Overview

  2019cited by this paper
• Total body irradiation for hematopoietic stem cell transplantation during early childhood is associated with the risk for diabetes mellitus

  2018cited by this paper
• Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span.

  2018cited by this paper
• Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999–2014)

  2018cited by this paper
• Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.

  2018cited by this paper
• The spectrum of type III hyperlipoproteinemia.

  2018cited by this paper
• Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study

  2018cited by this paper
• Simplified Canadian Definition for Familial Hypercholesterolemia.

  2018cited by this paper
• Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score".

  2018cited by this paper
• Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association

  2018cited by this paper
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.

  2017cited by this paper
• Effectiveness of Lipid-Lowering Statin Therapy in Patients With and Without Psoriasis

  2017cited by this paper
• Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis.

  2017cited by this paper
• Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults: The ALLHAT-LLT Randomized Clinical Trial

  2017cited by this paper
• Sex Steroids and Cardiovascular Outcomes in Transgender Individuals: A Systematic Review and Meta‐Analysis

  2017cited by this paper
• Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association

  2016cited by this paper
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.

  2016cited by this paper
• Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.

  2016cited by this paper
• Impact of Statin Use After Heart Transplantation: A Meta-Analysis

  2016cited by this paper
• Hypertriglyceridemia-induced acute pancreatitis in pregnancy causing maternal death

  2016cited by this paper
• Clinical features and treatment of hypertriglyceridemia‐induced acute pancreatitis during pregnancy: A retrospective study

  2016cited by this paper
• Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis.

  2016cited by this paper
• Medical nutrition therapy is the essential cornerstone for effective treatment of "refractory" severe hypertriglyceridemia regardless of pharmaceutical treatment: Evidence from a Lipid Management Program.

  2015cited by this paper
• Statin use and mortality in rheumatoid arthritis: a general population-based cohort study

  2015cited by this paper
• Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial.

  2015cited by this paper
• A 23‐year, single‐center, retrospective analysis of 36 cases of acute pancreatitis in pregnancy

  2015cited by this paper
• Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

  2015cited by this paper

• Endocrine Practice: Another Year of High-Impact Endocrinology Research and Reviews.

  2026cites this paper
• Applications of genetic testing in cardiovascular disease.

  2026cites this paper
• Statins and Type 1 Diabetes: Impact on Cardiovascular Outcomes and surrogates. Systematic Review and meta-analysis

  2025cites this paper
• Advances in Beyond Statin Lipid Therapies for ASCVD Risk Reduction

  2025cites this paper
• Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP).

  2025cites this paper
• Potential Molecular Biomarkers for Predicting and Monitoring Complications in Type 2 Diabetes Mellitus

  2025cites this paper